Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stereoselective synthesis from a process research perspective.

Michael C Hillier1, Paul J Reider

  • 1Department of Process Research, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. michael_hillier@merck.com

Drug Discovery Today
|February 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-Nitrosamine Formation in Pharmaceutical Solid Drug Products: Experimental Observations.

Journal of pharmaceutical sciences·2023
Same author

A Novel, Highly Enantioselective Ketone Alkynylation Reaction Mediated by Chiral Zinc Aminoalkoxides.

Angewandte Chemie (International ed. in English)·2018
Same author

Diastereoselective syntheses of substituted cis-hydrindanones featuring sequential inter- and intramolecular Michael reactions.

Tetrahedron·2016
Same author

Targeting NAD+ metabolism in the human malaria parasite Plasmodium falciparum.

PloS one·2014
Same author

A concise and convergent synthesis of PA-824.

The Journal of organic chemistry·2010
Same author

Designed ligands as probes for the catalytic binding mode in Mo-catalyzed asymmetric allylic alkylation.

Angewandte Chemie (International ed. in English)·2009
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
See all related articles

Developing single-isomer chiral drugs is crucial for pharmaceutical safety and efficacy. Process chemists face challenges due to limited synthetic methods, requiring creative solutions for reproducible drug synthesis.

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Pharmaceutical Development

Background:

  • Process chemists synthesize active pharmaceutical ingredients (APIs).
  • Chiral molecules must often be produced as single isomers for regulatory compliance.
  • Isomeric impurities in pharmaceuticals are generally unacceptable, even at low levels.

Purpose of the Study:

  • To highlight the challenges in synthesizing single-isomer chiral drugs.
  • To emphasize the need for advanced synthetic methodologies in pharmaceutical development.

Main Methods:

  • Review of current synthetic strategies for chiral drug development.
  • Analysis of limitations in existing chemical methods.
  • Discussion of the role of creativity and effort in process chemistry.

Related Experiment Videos

Main Results:

  • The synthesis of enantiomerically pure compounds presents significant hurdles.
  • Existing chemical tools for chiral synthesis are often insufficient.
  • Achieving functional and consistent chiral syntheses demands substantial innovation.

Conclusions:

  • Developing efficient and reproducible syntheses for single-isomer chiral drugs is a complex task.
  • Overcoming limitations in current synthetic chemistry is essential for pharmaceutical manufacturing.
  • Process chemists require advanced understanding and creative approaches to meet regulatory standards.